From ischaemia to heart failure: Heart rate - Actor or stamper?

被引:1
|
作者
Lechat, P [1 ]
机构
[1] Hop La Pitie Salpetriere, Serv Pharmacol, F-75013 Paris, France
来源
THERAPIE | 2004年 / 59卷 / 05期
关键词
heart rate; ischaemia; contractility; beta-blocker; ivabradine; heart failure;
D O I
10.2515/therapie:2004084
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The heart rate in sinus rhythm depends on I-f current-induced automaticity of sinus node cells. Such a current is activated by hyperpolarisation and is modulated by influences from sympathetic and para-sympathetic tones. There are established prognostic values for the baseline heart rate and its variability in coronary heart disease and heart failure. However. heart rate per se directly modulates myocardial oxygen consumption and cardiac contractility by interfering with the excitation-contraction coupling. The therapeutic implications of pharmacological modulation of the heart rate are important mainly for slowing the heart rate, as illustrated by the use of calcium antagonists in coronary heart disease and beta-blockers in both coronary heart disease and heart failure. The possibility of a direct action on sinusal automaticity by drugs such as ivabradine, an I-f channel blocker, reveals new therapeutic perspectives. Indeed, a benefit of combination therapy with these drugs and beta-blockers should be lower heart rate values than can be attained with maximally tolerated doses of beta-blockers.
引用
收藏
页码:485 / 489
页数:5
相关论文
共 50 条
  • [1] Heart Rate in Coronary Syndromes and Heart Failure
    Orso, Francesco
    Baldasseroni, Samuele
    Maggioni, Aldo Pietro
    PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (01) : 38 - 45
  • [2] Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study)
    Fu, M.
    Ahrenmark, U.
    Berglund, S.
    Lindholm, C. J.
    Lehto, A.
    Broberg, A. Mansson
    Tasevska-Dinevska, G.
    Wikstrom, G.
    Agard, A.
    Andersson, B.
    CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (12) : 960 - 973
  • [3] Heart rate and experimental myocardial ischaemia
    Berdeaux, A
    Colin, P
    Monnet, X
    Ghaleh, B
    THERAPIE, 2004, 59 (05): : 507 - 510
  • [4] Is Heart Rate a Norepiphenomenon in Heart Failure?
    Hensey, Mark
    O'Neill, James
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (09)
  • [5] Management of heart rate in heart failure
    Luis Barisani, Jose
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 88 - 95
  • [6] Heart rate and its reduction in chronic heart failure and beyond
    Vukadinovic, Aleksandra Nikolovska
    Vukadinovic, Davor
    Borer, Jeffrey
    Cowie, Martin
    Komajda, Michel
    Lainscak, Mitja
    Swedberg, Karl
    Boehm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (10) : 1230 - 1241
  • [7] The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
    Abozguia, K.
    Shivu, G. Nallur
    Ahmed, I.
    Phan, T. T.
    Frenneaux, M. P.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (08) : 827 - 835
  • [8] Heart Rate As a Biomarker in Heart Failure: Role of Heart Rate Lowering Agents
    Shaaya, Ghazwan
    Al-Khazaali, Ali
    Arora, Rohit
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E532 - E539
  • [9] Heart rate as a therapeutic target in heart failure?
    Tavazzi, L
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2003, 5 (0G) : G15 - G18
  • [10] Heart rate and heart failure
    Yip, Amelia M. C.
    Zhai, Alexander B.
    Haddad, Haissam
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (02) : 204 - 208